Expression of Prostate-Specific Membrane Antigen in Normal and Malignant Human Tissues

[1]  Shankar Vallabhajosula,et al.  Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Silva,et al.  A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer , 2004, Cancer Research.

[3]  H. Akino,et al.  Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat. , 2004, The Journal of urology.

[4]  W. Heston,et al.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer , 2004, Journal of cellular biochemistry.

[5]  D. O’Keefe,et al.  Comparative analysis of prostate‐specific membrane antigen (PSMA) versus a prostate‐specific membrane antigen‐like gene , 2004, The Prostate.

[6]  Thomas D. Schmittgen,et al.  Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients , 2003, International journal of cancer.

[7]  A. Bodner,et al.  Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Haas,et al.  Inhibition of prostate‐specific membrane antigen (PSMA)‐positive tumor growth by vaccination with either full‐length or the C‐terminal end of PSMA , 2002, International journal of cancer.

[9]  S. Cingarlini,et al.  Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen , 2002, The Prostate.

[10]  W. Tong,et al.  Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase , 2001, Mammalian Genome.

[11]  B. Tombal,et al.  Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  P. Triozzi,et al.  Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. , 2000, Cancer research.

[13]  C. Botev,et al.  Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial , 2000, European Urology.

[14]  R L Sokoloff,et al.  A dual‐monoclonal sandwich assay for prostate‐specific membrane antigen: Levels in tissues, seminal fluid and urine , 2000, The Prostate.

[15]  V. Reuter,et al.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.

[16]  J. Neefs,et al.  Isolation and Expression of Novel Human Glutamate Carboxypeptidases with N-Acetylated α-Linked Acidic Dipeptidase and Dipeptidyl Peptidase IV Activity* , 1999, The Journal of Biological Chemistry.

[17]  V. Paradis,et al.  Molecular expression of PSMA mRNA and protein in primary renal tumors , 1999, International journal of cancer.

[18]  G. Murphy,et al.  Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen. , 1998, The Journal of urology.

[19]  R. Wolfert,et al.  Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line. , 1998, Cancer research.

[20]  D. Bostwick,et al.  Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. , 1998, Urology.

[21]  J. Coyle,et al.  Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). , 1998, The Journal of pharmacology and experimental therapeutics.

[22]  H. Klocker,et al.  Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. , 1998, Urology.

[23]  J. Coyle,et al.  Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Neale,et al.  Molecular Cloning of a Peptidase Against N‐Acetylaspartylglutamate from a Rat Hippocampal cDNA Library , 1997, Journal of neurochemistry.

[25]  J Barrett,et al.  Characterisation and properties of an intracellular lipid-binding protein from the tapeworm Moniezia expansa. , 1997, European journal of biochemistry.

[26]  A. Barrett,et al.  Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme Nomenclature. Recommendations 1992. Supplement 4: corrections and additions (1997). , 1997, European journal of biochemistry.

[27]  J. Nakayama,et al.  Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. , 1997, Cancer research.

[28]  J. Coyle,et al.  Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  George L. Wright,et al.  Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids , 1995, International journal of cancer.

[30]  W. Fair,et al.  Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. , 1995, Cancer research.

[31]  R. Babaian,et al.  Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356. , 1994, The Journal of urology.

[32]  Tipton Kf.  Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme nomenclature. Recommendations 1992. Supplement: corrections and additions. , 1994 .

[33]  W. Fair,et al.  Expression of the prostate-specific membrane antigen. , 1994, Cancer research.

[34]  B. Martin,et al.  Characteristics of a purified dog hepatic microsomal N,O-acyltransferase. , 1994, Carcinogenesis.

[35]  W. Fair,et al.  Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. , 1993, Cancer research.

[36]  A. Conversi,et al.  A COMPARATIVE ANALYSIS) , 2008 .

[37]  G. Haas,et al.  Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer , 2005, Prostate Cancer and Prostatic Diseases.

[38]  Nomenclature committee of the international union of biochemistry and molecular biology (NC-IUBMB), Enzyme Supplement 5 (1999). , 1999, European journal of biochemistry.

[39]  C. Cordon-Cardo,et al.  Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  L. L. Lloyd,et al.  Enzyme nomenclature — Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology: Academic Press Ltd, London, UK, 1992. xiii + 862 pp. Price £40.00. ISBN 0-12-227165-3 , 1994 .